| Literature DB >> 31933859 |
Wenchao Zhao1, Wenqi Li2, Xin Jin1, Tianli Niu1, Yuanfei Cao1, Peng Zhou1, Minghua Zheng1.
Abstract
It has been proven that NEAT1 as a long non-coding RNA (lncRNA) is highly expressed in bladder cancer (BC). Nevertheless, the oncogenic roles of NEAT1 in BC remain largely unknown. In the present study, we observed that the RNA level of NEAT1.1, one RNA variant of NEAT1, was reduced in cisplatin-sensitive T24 cells compared to cisplatin-resistant T24 (T24R) cells after both treated with cisplatin modulated through Wnt/β-catenin signaling pathway using RNA-seq. Furthermore, NEAT1.1 was knocked down within T24R cells and caused a phenotype of the compromised cell growth, invasion and enhanced apoptosis upon cisplatin treatment compared to untreated T24R cells. Finally, c-MYC, OCT4 and p53 were determined to contribute to the transcriptional regulation of NEAT1.1 under cisplatin using ChIP assay. Taken together, our results suggest that NEAT1.1 blocking can promote the effect of cisplatin for BC treatment. IJCEPEntities:
Keywords: NEAT1; bladder cancer; cisplatin; lncRNA
Year: 2019 PMID: 31933859 PMCID: PMC6945077
Source DB: PubMed Journal: Int J Clin Exp Pathol ISSN: 1936-2625